Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline, Nicotine Lozenges, and Smartphone App for Smoking Cessation
NCT07099638Phase 2Recruiting
- Sponsor
- University of Oklahoma
- Start
- Jul 2026
- Primary completion
- Jun 2029
- Countries
- 1
01
Overview
A Phase 2 trial of nicotine in Tobacco Use Disorder (TUD), sponsored by University of Oklahoma. Started Jul 2026; status: recruiting.
02
Drugs
nicotine
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT07099638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07099638.